441 related articles for article (PubMed ID: 31203554)
1. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
2. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
4. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
[TBL] [Abstract][Full Text] [Related]
5. The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Xing W; Gao W; Lv X; Zhao Z; Mao G; Dong X; Zhang Z
Front Nutr; 2022; 9():1024678. PubMed ID: 36386939
[TBL] [Abstract][Full Text] [Related]
6. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
[TBL] [Abstract][Full Text] [Related]
7. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
8. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
Front Nutr; 2022; 9():880014. PubMed ID: 35669067
[TBL] [Abstract][Full Text] [Related]
9. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Guo XF; Wang C; Yang T; Li S; Li KL; Li D
Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
[TBL] [Abstract][Full Text] [Related]
11. The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis.
Li S; Liu J; Wang Z; Duan F; Jia Z; Chen X; Li S
Front Public Health; 2022; 10():862266. PubMed ID: 35958869
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease.
Çakır M; Aksel İşbilen A; Eyüpoğlu İ; Sağ E; Örem A; Mazlum Şen T; Kaklıkkaya N; Kaya G
Turk J Gastroenterol; 2017 Sep; 28(5):377-383. PubMed ID: 28797988
[TBL] [Abstract][Full Text] [Related]
13. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
Wang W; Shi LP; Shi L; Xu L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
[No Abstract] [Full Text] [Related]
16. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
17. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients.
Buss C; Valle-Tovo C; Miozzo S; Alves de Mattos A
Ann Hepatol; 2014; 13(5):482-8. PubMed ID: 25152979
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Probiotics/Synbiotics on Glucose and Lipid Metabolism in Women with Gestational Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
Mu J; Guo X; Zhou Y; Cao G
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986107
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses.
Mahapatro A; Bawna F; Kumar V; Daryagasht AA; Gupta S; Raghuma N; Moghdam SS; Kolla A; Mahapatra SS; Sattari N; Amini-Salehi E; Nayak SS
Clin Nutr ESPEN; 2023 Oct; 57():475-486. PubMed ID: 37739694
[TBL] [Abstract][Full Text] [Related]
20. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
Wang Y; Wang Y; Sun J
Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
